Drugs for Sclerosing Cholangitis (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):
(show top 50)
(show all 103)
# |
|
Name |
Status |
Phase |
Clinical Trials |
Cas Number |
PubChem Id |
1 |
|
Vancomycin |
Approved |
Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable |
|
1404-90-6 |
14969
441141
|
Synonyms:
(1S,2R,18R,22S,25R,28R,40S)-22-(2-amino-2-Oxoethyl)-48-[2-O-(3-amino-2,3,6-trideoxy-3-methyl-a-L-lyxo-hexopyranosyl)-b-D-glucopyranosyloxy]-5,15-dichloro-2,18,32,35,37-pentahydroxy-19-[(N-methyl-D-leucyl)amino]-20,23,26,42,44-pentaoxo-7,13-dioxa-21,24,27,41,43-pentaazaoctacyclo[26.14.2.2(3,6).2(14,17).1(8,12).1(29,33).0(10,25).0(34,39)]pentaconta-3,5,8(48),9,11,14,16,29(45),30,32,34,36,38,46,49-pentadecaene-40-carboxylate
(1S,2R,18R,22S,25R,28R,40S)-22-(2-amino-2-Oxoethyl)-48-[2-O-(3-amino-2,3,6-trideoxy-3-methyl-a-L-lyxo-hexopyranosyl)-b-D-glucopyranosyloxy]-5,15-dichloro-2,18,32,35,37-pentahydroxy-19-[(N-methyl-D-leucyl)amino]-20,23,26,42,44-pentaoxo-7,13-dioxa-21,24,27,41,43-pentaazaoctacyclo[26.14.2.2(3,6).2(14,17).1(8,12).1(29,33).0(10,25).0(34,39)]pentaconta-3,5,8(48),9,11,14,16,29(45),30,32,34,36,38,46,49-pentadecaene-40-carboxylic acid
(1S,2R,18R,22S,25R,28R,40S)-22-(2-amino-2-Oxoethyl)-48-[2-O-(3-amino-2,3,6-trideoxy-3-methyl-alpha-L-lyxo-hexopyranosyl)-beta-D-glucopyranosyloxy]-5,15-dichloro-2,18,32,35,37-pentahydroxy-19-[(N-methyl-D-leucyl)amino]-20,23,26,42,44-pentaoxo-7,13-dioxa-21,24,27,41,43-pentaazaoctacyclo[26.14.2.2(3,6).2(14,17).1(8,12).1(29,33).0(10,25).0(34,39)]pentaconta-3,5,8(48),9,11,14,16,29(45),30,32,34,36,38,46,49-pentadecaene-40-carboxylate
(1S,2R,18R,22S,25R,28R,40S)-22-(2-amino-2-Oxoethyl)-48-[2-O-(3-amino-2,3,6-trideoxy-3-methyl-alpha-L-lyxo-hexopyranosyl)-beta-D-glucopyranosyloxy]-5,15-dichloro-2,18,32,35,37-pentahydroxy-19-[(N-methyl-D-leucyl)amino]-20,23,26,42,44-pentaoxo-7,13-dioxa-21,24,27,41,43-pentaazaoctacyclo[26.14.2.2(3,6).2(14,17).1(8,12).1(29,33).0(10,25).0(34,39)]pentaconta-3,5,8(48),9,11,14,16,29(45),30,32,34,36,38,46,49-pentadecaene-40-carboxylic acid
(1S,2R,18R,22S,25R,28R,40S)-22-(2-amino-2-Oxoethyl)-48-[2-O-(3-amino-2,3,6-trideoxy-3-methyl-α-L-lyxo-hexopyranosyl)-β-D-glucopyranosyloxy]-5,15-dichloro-2,18,32,35,37-pentahydroxy-19-[(N-methyl-D-leucyl)amino]-20,23,26,42,44-pentaoxo-7,13-dioxa-21,24,27,41,43-pentaazaoctacyclo[26.14.2.2(3,6).2(14,17).1(8,12).1(29,33).0(10,25).0(34,39)]pentaconta-3,5,8(48),9,11,14,16,29(45),30,32,34,36,38,46,49-pentadecaene-40-carboxylate
(1S,2R,18R,22S,25R,28R,40S)-22-(2-amino-2-Oxoethyl)-48-[2-O-(3-amino-2,3,6-trideoxy-3-methyl-α-L-lyxo-hexopyranosyl)-β-D-glucopyranosyloxy]-5,15-dichloro-2,18,32,35,37-pentahydroxy-19-[(N-methyl-D-leucyl)amino]-20,23,26,42,44-pentaoxo-7,13-dioxa-21,24,27,41,43-pentaazaoctacyclo[26.14.2.2(3,6).2(14,17).1(8,12).1(29,33).0(10,25).0(34,39)]pentaconta-3,5,8(48),9,11,14,16,29(45),30,32,34,36,38,46,49-pentadecaene-40-carboxylic acid
(1S,2R,18R,22S,25R,28R,40S)-22-(2-amino-2-oxoethyl)-48-[2-O-(3-amino-2,3,6-trideoxy-3-methyl-α-L-lyxo-hexopyranosyl)-β-D-glucopyranosyloxy]-5,15-dichloro-2,18,32,35,37-pentahydroxy-19-[(N-methyl-D-leucyl)amino]-20,23,26,42,44-pentaoxo-7,13-dioxa-21,24,27,41,43-pentaazaoctacyclo[26.14.2.23,6.214,17.18,12.129,33.010,25.034,39]pentaconta-3,5,8(48),9,11,14,16,29(45),30,32,34,36,38,46,49-pentadecaene-40-carboxylic acid
(2.2Sp,3.5Sa,2.6Sp)-O(4.2),C(3.4):C(5.4),O(4.6):c(3.5),C(2.7)-tricyclo[N-methyl-D-leucyl-3-chloro-(R)-beta-hydroxy-D-tyrosyl-L-asparaginyl-D-2-(4-{[2-O-(3-amino-2,3,6-trideoxy-3-C-methyl-alpha-L-lyxo-hexopyranosyl)-beta-D-glucopyranosyl]oxy}phenyl)glycyl-D-2-(4-hydroxyphenyl)glycyl-3-chloro-(R)-beta-hydroxy-L-tyrosyl-L-2-(3,5-dihydroxyphenyl)glycine]
(2.2Sp,3.5Sa,2.6Sp)-O(4.2),C(3.4):C(5.4),O(4.6):c(3.5),C(2.7)-tricyclo[N-methyl-D-leucyl-3-chloro-(R)-b-hydroxy-D-tyrosyl-L-asparaginyl-D-2-(4-{[2-O-(3-amino-2,3,6-trideoxy-3-C-methyl-a-L-lyxo-hexopyranosyl)-b-D-glucopyranosyl]oxy}phenyl)glycyl-D-2-(4-hydroxyphenyl)glycyl-3-chloro-(R)-b-hydroxy-L-tyrosyl-L-2-(3,5-dihydroxyphenyl)glycine]
(2.2Sp,3.5Sa,2.6Sp)-O(4.2),C(3.4):C(5.4),O(4.6):c(3.5),C(2.7)-tricyclo[N-methyl-D-leucyl-3-chloro-(R)-β-hydroxy-D-tyrosyl-L-asparaginyl-D-2-(4-{[2-O-(3-amino-2,3,6-trideoxy-3-C-methyl-α-L-lyxo-hexopyranosyl)-β-D-glucopyranosyl]oxy}phenyl)glycyl-D-2-(4-hydroxyphenyl)glycyl-3-chloro-(R)-β-hydroxy-L-tyrosyl-L-2-(3,5-dihydroxyphenyl)glycine]
(2.2Sp,3.5Sa,2.6Sp)-O4.2,C3.4:C5.4,O4.6:C3.5,C2.7-tricyclo[N-methyl-D-leucyl-3-chloro-(R)-β-hydroxy-D-tyrosyl-L-asparaginyl-D-2-(4-{[2-O-(3-amino-2,3,6-trideoxy-3-C-methyl-α-L-lyxo-hexopyranosyl)-β-D-glucopyranosyl]oxy}phenyl)glycyl-D-2-(4-hydroxyphenyl)glycyl-3-chloro-(R)-β-hydroxy-L-tyrosyl-L-2-(3,5-dihydroxyphenyl)glycine]
1404-90-6
1404-93-9 (hydrochloride)
64685-75-2 (sulfate)
Abbott brand OF vancomycin hydrochloride
AB-vancomycin
AC1L24VU
AC1L9AMI
AC1Q29OH
Azupharma brand OF vancomycin hydrochloride
BIDD:GT0353
C06689
C66H75Cl2N9O24
Cell pharm brand OF vancomycin hydrochloride
CHEBI:28001
CHEMBL262777
Chiesi brand OF vancomycin hydrochloride
CID14969
CID441141
CID5311496
CID6426898
CID6917992
combino Brand OF vancomycin hydrochloride
Curasan brand OF vancomycin hydrochloride
D00212
Dakota brand OF vancomycin hydrochloride
DB00512
Diatracin
Dista brand OF vancomycin hydrochloride
EINECS 215-772-6
Eli lilly brand OF vancomycin hydrochloride
Hexal brand OF vancomycin hydrochloride
HSDB 3262
Hydrochloride, vancomycin
Lilly brand OF vancomycin hydrochloride
LMPK14000004
|
Lopac0_001267
LS-161387
MIP brand OF vancomycin hydrochloride
MolPort-001-794-649
NCGC00162383-02
nchembio.350-comp1
Norman brand OF vancomycin hydrochloride
Prestwick0_000497
Prestwick1_000497
Prestwick2_000497
Ratiopharm brand OF vancomycin hydrochloride
SPBio_002314
Sulfate, vancomycin
UNII-6Q205EH1VU
VAN
vanco Azupharma
vanco-Cell
Vancocin
Vancocin (TN)
Vancocin HCL
Vancocine
Vancomicin
Vancomicina
Vancomicina [INN-Spanish]
Vancomicina abbott
Vancomicina chiesi
Vancomicina combino phar
Vancomicina norman
VANCOMYCIN
Vancomycin (USP)
Vancomycin [USAN:INN:BAN]
Vancomycin HCL
Vancomycin hexal
Vancomycin hydrochloride
Vancomycin lilly
Vancomycin phosphate (1:2)
Vancomycin phosphate (1:2), decahydrate
Vancomycin sulfate
Vancomycine
Vancomycine [INN-French]
Vancomycine dakota
Vancomycin-ratiopharm
Vancomycinum
Vancomycinum [INN-Latin]
vanco-Saar
|
|
2 |
|
Ofloxacin |
Approved |
Phase 4 |
|
82419-36-1 |
4583
|
Synonyms:
( -)-9-Fluoro-2,3-dihydro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-7H-pyrido(1,2,3-de)(1,4)benzoxazin-6-carbonsaeure
(+-)-9-Fluoro-2,3-dihydro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-7H-pyrido(1,2,3-de)-1,4-benzoxazine-6-carboxylic acid
(+/-)-9-Fluoro-2,3-dihydro-3-methyl-10-(4-methyl-1-piperaz inyl)-7-oxo-7H-pyrido(1,2,3-de)-1,4-benzoxazine-6-carboxylic acid
(+/-)-9-Fluoro-2,3-dihydro-3-methyl-10-(4-methyl-1-piperazinyl)-7- -oxo-7H-pyrido(1,2,3-de)- -1,4-benzoxazine-6-carboxylic acid
(+/-)-9-Fluoro-2,3-dihydro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-7H-pyrido[1,2,3-de]-1,4-benzoxazine-6-carboxylic acid
(+/-)-Floxin
118120-51-7 (hydrochloride)
33703_FLUKA
33703_RIEDEL
82419-36-1
83380-47-6
85344-55-4
8-fluoro-3-Methyl-9-(4-methyl-piperazin-1-yl)-6-oxo-2,3-dihydro-6H-1-oxa-3a-aza-phenalene-5-carboxylate
8-fluoro-3-Methyl-9-(4-methyl-piperazin-1-yl)-6-oxo-2,3-dihydro-6H-1-oxa-3a-aza-phenalene-5-carboxylic acid
8-Fluoro-3-methyl-9-(4-methyl-piperazin-1-yl)-6-oxo-2,3-dihydro-6H-1-oxa-3a-aza-phenalene-5-carboxylic acid
9-fluoro-3-methyl-10-(4-methylpiperazin-1-yl)-7-oxo-2,3-dihydro-7H-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxylic acid
AB00513820
AC1L1IHM
AC-7616
AKOS001033517
Bactocin
BB_SC-1252
BPBio1_000345
BRD-A24228527-001-05-9
BRN 3657947
BSPBio_000313
BSPBio_003117
C07321
C18H20FN3O4
CCRIS 5233
CHEBI:7731
CHEMBL4
CID4583
CPD000058192
D00453
Danoflox
DB01165
DEXTROFLOXACINE
DivK1c_000721
DL 8280
DL-8280
DL-8280, HOE-280, Exocin, Flobacin, Floxin, Floxil, Monoflocet, Ofloxacin
Effexin
EU-0100904
Exocin
Exocine
Flobacin
Flodemex
Flotavid
Flovid
Floxal
Floxil
Floxin
Floxin (TN)
FLOXIN IN DEXTROSE 5%
FLOXIN IN DEXTROSE 5% IN PLASTIC CONTAINER
Floxin otic
Floxstat
Fugacin
HMS1568P15
HMS1921H12
HMS2090F07
HMS2092B10
HMS502E03
Hoe 280
HOE 280
Hoe-280
I06-0112
I06-0380
IDI1_000721
Inoflox
KBio1_000721
KBio2_001666
KBio2_004234
KBio2_006802
KBio3_002617
KBioGR_000667
KBioSS_001666
Kinflocin
Kinoxacin
Liflox
Lopac0_000904
Loxinter
LS-133259
Marfloxacin
Medofloxine
Mergexin
MLS000028749
MLS001074203
MolPort-000-422-241
MolPort-000-873-068
NCGC00015772-02
NCGC00015772-10
|
NCGC00094219-01
NCGC00094219-02
NCGC00094219-03
NCGC00094219-04
NCGC00094219-05
NCGC00094219-06
NCGC00178284-01
NCGC00178284-02
NINDS_000721
Novecin
NSC727071
Nufafloqo
O 8757
O8757_SIGMA
Obide
Occidal
Ocuflox
Ofcin
Oflin
Oflocee
Oflocet
Oflocin
Oflodal
Oflodex
Oflodura
Oflox
O-Flox
ofloxacin
Ofloxacin (JP15/USP/INN)
Ofloxacin [USAN:BAN:INN:JAN]
Ofloxacin hydrochloride
Ofloxacin Otic
Ofloxacin, (S)-Isomer
Ofloxacina
Ofloxacina [DCIT]
Ofloxacine
Ofloxacine [French]
Ofloxacino
Ofloxacino [Spanish]
Ofloxacinum
Ofloxacinum [Latin]
Ofloxin
OFLX
Ofus
OFX
Onexacin
Operan
Oprea1_242882
ORF 18489
ORF-28489
Orocin
Otonil
Oxaldin
Pharflox
Praxin
Prestwick0_000237
Prestwick1_000237
Prestwick2_000237
Prestwick3_000237
PT 01
Puiritol
Qinolon
Qipro
Quinolon
Quotavil
Rilox
Ru-43280
S1463_Selleck
SAM002264629
Sinflo
SMR000058192
SPBio_001387
SPBio_002234
Spectrum_001186
SPECTRUM1502044
Spectrum2_001464
Spectrum3_001499
Spectrum4_000324
Spectrum5_001063
STK256723
Tabrin
Taravid
Tariflox
Tarivid
Telbit
Tructum
UNII-A4P49JAZ9H
Uro Tarivid
Viotisone
Visiren
WP-0405
XED
Zanocin
|
|
3 |
|
Levofloxacin |
Approved, Investigational |
Phase 4 |
|
100986-85-4 |
149096
|
Synonyms:
(−
(-)-(S)-9-Fluoro-2,3-dihydro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-7H-pyrido(1,2,3-de)-1,4-benzoxazine-6-carboxylic acid
(-)-(S)-9-fluoro-2,3-dihydro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-7Hpyrido[1,2,3-de]-1,4-benzoxazine-6-carboxylic acid hemihydrate
(-)-(S)-9-fluoro-2,3-dihydro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-7H-pyridol[1,2,3-de]-1,4-benzoxazine-6-carboxylic acid hemihydrate
(-)-Ofloxacin
(3S)-(-)-9-fluoro-3-Methyl-10-(4-methyl-1-piperazinyl)-7-oxo-2,3-dihydro-7H-pyrido[1,2,3-de][1,4]benzoxazine-6-carboxylate
(3S)-(-)-9-fluoro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-2,3-dihydro-7H-pyrido[1,2,3-de][1,4]benzoxazine-6-carboxylic acid
(3S)-(-)-9-fluoro-3-Methyl-10-(4-methyl-1-piperazinyl)-7-oxo-2,3-dihydro-7H-pyrido[1,2,3-de][1,4]benzoxazine-6-carboxylic acid
(3S)-9-fluoro-3-methyl-10-(4-methylpiperazin-1-yl)-7-oxo-2,3-dihydro-7H-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxylic acid
(R)-9-Fluoro-2,3-dihydro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-7H-pyrido(1,2,3-de)-1,4-benzoxazine-6-carboxylic acid
(R)-isomer
(S)-(-)-9-fluoro-3-Methyl-10-(4-methyl-1-piperazinyl)-7-oxo-2,3-dihydro-7H-pyrido[1,2,3-de][1,4]benzooxazine-6-carboxylate
(S)-(-)-9-fluoro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-2,3-dihydro-7H-pyrido[1,2,3-de][1,4]benzooxazine-6-carboxylic acid
(S)-(-)-9-fluoro-3-Methyl-10-(4-methyl-1-piperazinyl)-7-oxo-2,3-dihydro-7H-pyrido[1,2,3-de][1,4]benzooxazine-6-carboxylic acid
(S)-(-)-Ofloxacin
(S)-9-fluoro-2,3-dihydro-3-Methyl-10-(4-methyl-1-piperazinyl)-7-oxo-7H-pyrido(1,2,3-de)-1,4-benzoxazine-6-carboxylate
(S)-9-fluoro-2,3-dihydro-3-Methyl-10-(4-methyl-1-piperazinyl)-7-oxo-7H-pyrido(1,2,3-de)-1,4-benzoxazine-6-carboxylic acid
(S)-9-Fluoro-2,3-dihydro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-7H-pyrido(1,2,3-de)-1,4-benzoxazine-6-carboxylic acid
(S)-Ofloxacin
)-Ofloxacin
100986-85-4
100986-86-5
28266_FLUKA
28266_SIGMA
AC1L3YF8
AC-7593
Aeroquin
Ambap100986-85-4
Anhydrous, levofloxacin
BRD-K09471561-001-06-7
BSPBio_002689
C07660
C18H20FN3O4
C18H20FN3O4.H2O
CCRIS 4073
CCRIS 4074
CHEMBL33
CID149096
CPD000466387
Cravit
Cravit (TN)
Cravit Ophthalmic
D08120
DB01137
d-Levofloxacin
DR 3354
DR3355
DR-3355
DR-3355: L-isomer of ofloxacin
Elequine
Floxacin
Floxel
Floxin
HMS1922J07
HMS2051G04
HMS2090O10
HMS2093E18
HR 355
HR-355
Iquix
KBio2_002199
|
KBio2_004767
KBio2_007335
KBio3_001909
KBioGR_001605
KBioSS_002199
L0193
Leroxacin
Lesacin
Levaquin
LEVAQUIN IN DEXTROSE 5% IN PLASTIC CONTAINER
LEVOFLOXACIN
Levofloxacin (INN)
Levofloxacin [USAN:INN:JAN]
Levofloxacin anhydrous
Levofloxacin hydrate
Levofloxacin tablet, suspension or intravenous
Levofloxacine
Levofloxacine [INN-French]
Levofloxacino
Levofloxacino [INN-Spanish]
Levofloxacinum
Levofloxacinum [INN-Latin]
Levokacin
Levox
Levoxacin
LFX
L-Ofloxacin
LS-133260
LS-171761
LVX
MLS000759524
MLS001165709
MLS001423977
MolPort-002-885-835
Mosardal
MP-376
NCGC00178529-01
Nofaxin
Ofloxacin
Ofloxacin S-(-)-form
Ofloxacin, (S)-isomer
Oftaquix
Quixin
Reskuin
R-Ofloxacin
RWJ 25213-097
RWJ-25213
S-(-)-Ofloxacin
S1940_Selleck
SAM001246758
SMR000466387
SPBio_001891
Spectrum_001719
SPECTRUM1504260
Spectrum2_001676
Spectrum3_000995
Spectrum4_001123
Spectrum5_001438
Tavanic
Volequin
|
|
4 |
|
Ceftriaxone |
Approved |
Phase 4 |
|
73384-59-5 |
5479530
5361919
|
Synonyms:
(6R,7R)-7-({(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-[(methyloxy)imino]acetyl}amino)-3-{[(6-hydroxy-2-methyl-5-oxo-2,5-dihydro-1,2,4-triazin-3-yl)thio]methyl}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
(6R,7R)-7-(2-(2-Amino-4-thiazolyl)glyoxylamido)-8-oxo-3-(((1,2,5,6-tetrahydro-2-methyl-5,6-dioxo-as-triazin-3-yl)thio)methyl)-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 7(sup 2)-(Z)-(O-methyloxime), sesquaterhydrate
(6R,7R)-7-[[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-methoxyiminoacetyl]amino]-3-[(2-methyl-5,6-dioxo-1H-1,2,4-triazin-3-yl)sulfanylmethyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
(6R,7R)-7-{[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-(methoxyimino)acetyl]amino}-3-{[(2-methyl-5,6-dioxo-1,2,5,6-tetrahydro-1,2,4-triazin-3-yl)sulfanyl]methyl}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
(6R,7R)-7-{[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-(methoxyimino)acetyl]amino}-3-{[(2-methyl-5,6-dioxo-1,2,5,6-tetrahydro-1,2,4-triazin-3-yl)sulfanyl]methyl}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
(6R,7R)-7-{[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-(methoxyimino)acetyl]amino}-3-{[(2-methyl-5,6-dioxo-1,2,5,6-tetrahydro-1,2,4-triazin-3-yl)sulphanyl]methyl}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
(6R,7R)-7-{[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-(methoxyimino)acetyl]amino}-3-{[(2-methyl-5,6-dioxo-1,2,5,6-tetrahydro-1,2,4-triazin-3-yl)sulphanyl]methyl}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
104376-79-6
104376-79-6 (di-hydrochloride salt)
73384-59-5
74578-69-1 (di-hydrochloride salt, hemiheptahydrate)
7beta-{[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-(methoxyimino)acetyl]amino}-3-{[(2-methyl-5,6-dioxo-1,2,5,6-tetrahydro-1,2,4-triazin-3-yl)sulfanyl]methyl}-3,4-didehydrocepham-4-carboxylic acid
AC-1592
AC1NUIFE
Anhydrous ceftriaxone sodium
Benaxona
Biotrakson
Boehringer mannheim brand OF ceftriaxone sodium
C06683
C18H18N8O7S3
Cefatriaxone
Cefaxona
Ceftrex
Ceftriaxon
Ceftriaxon curamed
Ceftriaxon hexal
Ceftriaxona
Ceftriaxona [INN-Spanish]
Ceftriaxona andreu
Ceftriaxona LDP torlan
ceftriaxone
Ceftriaxone (INN)
Ceftriaxone (TN)
Ceftriaxone [USAN:JAN]
Ceftriaxone intravenous
Ceftriaxone irex
Ceftriaxone sodium
CEFTRIAXONE SODIUM
Ceftriaxone sodium, anhydrous
Ceftriaxone, disodium salt
Ceftriaxone, Disodium Salt
|
Ceftriaxone, disodium salt, hemiheptahydrate
Ceftriaxone, Disodium Salt, Hemiheptahydrate
Ceftriaxonum
Ceftriaxonum [INN-Latin]
Ceftriazone
CHEBI:29007
CHEMBL161
CID5479530
Columbia brand OF ceftriaxone
CTRX
Curamed brand OF ceftriaxone sodium
D07659
DB01212
DRG-0071
EINECS 277-405-6
Fustery brand OF ceftriaxone sodium
Galen brand OF ceftriaxone sodium
Hexal brand OF ceftriaxone sodium
Hoffman la roche brand OF ceftriaxone sodium
Hoffman-la roche brand OF ceftriaxone sodium
Inibsa brand OF ceftriaxone sodium
Irex brand OF ceftriaxone
Lendacin
Longacef
Longaceph
LS-150031
MolPort-005-933-495
Pisa brand OF ceftriaxone sodium
Ro 139904
Ro13-9904
Ro-13-9904
Rocefalin
Rocefin
Rocephin
Rocephine
Roche brand OF ceftriaxone sodium
Sodium, ceftriaxone
Syntex brand OF ceftriaxone sodium
Tacex
Terbac
UNII-75J73V1629
|
|
5 |
|
Prednisolone |
Approved, Vet_approved |
Phase 4 |
|
50-24-8 |
5755
|
Synonyms:
(11b)-11,17,21-Trihydroxypregna-1,4-diene-3,20-dione
(11beta)-11,17,21-Trihydroxypregna-1,4-diene-3,20-dione
(11β)-11,17,21-trihydroxypregna-1,4-diene-3,20-dione
.DELTA.1-Cortisol
.DELTA.1-Dehydrocortisol
.DELTA.1-Dehydrohydrocortisone
.DELTA.1-Hydrocortisone
.delta.-Cortef
.delta.-Stab
1,2-Dehydrohydrocortisone
1,4-Pregnadiene-11b,17a,21-triol-3,20-dione
1,4-Pregnadiene-11beta,17alpha,21-triol-3,20-dione
1,4-pregnadiene-11β,17α,21-triol-3,20-dione
1,4-Pregnadiene-11β,17α,21-triol-3,20-dione
1,4-Pregnadiene-3,20-dione-11b,17a,21-triol
1,4-Pregnadiene-3,20-dione-11beta,17alpha,21-triol
1,4-pregnadiene-3,20-dione-11β,17α,21-triol
1,4-Pregnadiene-3,20-dione-11β,17α,21-triol
1-Dehydrocortisol
1-Dehydrohydrocortisone
3,20-dioxo-11b,17a,21-Trihydroxy-1,4-pregnadiene
3,20-dioxo-11beta,17alpha,21-Trihydroxy-1,4-pregnadiene
3,20-dioxo-11β,17α,21-trihydroxy-1,4-pregnadiene
46656_FLUKA
46656_RIEDEL
50-24-8
58201-11-9
8056-11-9
AC-1773
AC1L1L2E
Ak-Pred
Ak-Tate
Alphadrol
Articulose-50
Bio-0666
BPBio1_000164
BRD-K98039984-001-03-0
BRN 1354103
BSPBio_000148
Bubbli-Pred
C07369
CCRIS 980
CHEBI:8378
CHEMBL131
CID5755
Codelcortone
Co-Hydeltra
CO-Hydeltra
component of Ataraxoid
component of K-Predne-Dome
Cordrol
Cortalone
Cotogesic
Cotolone
CPD000718761
D00472
D011239
DB00860
Decaprednil
Decortin H
Delcortol
Delta F
delta(1)-Cortisol
delta(1)-Dehydrocortisol
Delta(1)-Dehydrocortisol
delta(1)-Dehydrohydrocortisone
Delta(1)-dehydrohydrocortisone
Delta(1)-Dehydrohydrocortisone
delta(1)-Hydrocortisone
Delta(1)-Hydrocortisone
delta(sup 1)-Cortisol
delta(sup 1)-Dehydrocortisol
delta(sup 1)-Dehydrohydrocortisone
delta(sup 1)-Hydrocortisone
Delta-Cortef
Delta-Cortef (TN)
Deltacortenol
Deltacortril
Deltacortril Enteric
delta-dehydrocortisol
delta-dehydrohydrocortisone
Delta-Ef-Cortelan
delta-hydrocortisone
Deltahydrocortisone
Deltasolone
Delta-stab
Delta-Stab
Deltisilone
Depo-Medrol
Derpo Pd
Derpo PD
Dexa-Cortidelt hostacortin H
Dexa-Cortidelt Hostacortin H
Di adreson F
Di Adreson F
Di-adreson F
Di-Adreson F
Di-adreson-F
DiAdresonF
Di-Adreson-F
Dicortol
Donisolone
Dydeltrone
Eazolin D
Econopred
Econopred Plus
EINECS 200-021-7
Erbacort
Erbasona
Estilsona
Fernisolone
Fernisolone P
Fernisolone-P
Flamasone
HMS1568H10
HMS2090J05
Hostacortin H
HSDB 3385
Hydeltra
Hydeltrasol
Hydeltra-Tba
|
Hydeltrone
Hydrodeltalone
Hydrodeltisone
Hydroretrocortin
Hydroretrocortine
Inflamase Forte
Inflamase Mild
I-Pred
K 1557
Key-Pred
Klismacort
Lentosone
Lite Pred
LMST02030179
LS-7669
Medrol
Medrol Acetate
Metacortandralone
Methylprednisolone acetate
Methylprednisolone Acetate
Meticortelone
Meti-Derm
Metreton
MLS001304083
MLS002154250
MLS002207037
MolPort-002-507-147
M-Predrol
NCGC00179649-01
Neo-Delta-Cortef
Nisolone
Nor-Pred T.B.A.
NSC 9120
NSC9120
NSC9900
Ocu-Pred
Ocu-Pred Forte
Ophtho-Tate
Orapred
P0152_SIGMA
P0637
P6004_SIGMA
Panafcortelone
Paracortol
Paracotol
Pediapred
Poly-Pred
PRDL
Precortalon
Precortancyl
Precortilon
Precortisyl
Pred Forte
Pred Mild
Predair
Predair A
Predair Forte
Predalone 50
Predalone T.B.A.
Predate
Predate Tba
Predate-50
Predcor-25
Predcor-50
Predcor-Tba
PRED-G
Predisolone sodium phosphate
Predisolone Sodium Phosphate
Predne-Dome
Prednelan
Prednicen
Predni-Dome
Predniliderm
Predniretard
Prednis
Prednisolona
Prednisolona [INN-Spanish]
prednisolone
Prednisolone (anhydrous)
Prednisolone (JP15/USP/INN)
Prednisolone [INN:BAN:JAN]
Prednisolone acetate
Prednisolone Acetate
Prednisolone sodium phosphate
Prednisolone Sodium Phosphate
Prednisolone tebutate
Prednisolone Tebutate
Prednisolonum
Prednisolonum [INN-Latin]
Predonin
Predonine
Prelone
Prenolone
Prestwick_404
Prestwick0_000274
Prestwick1_000274
Prestwick2_000274
Prestwick3_000274
Rolisone
S1737_Selleck
SAM002264639
Scherisolon
SMR000718761
Solone
SPBio_002367
Steran
Sterane
Sterolone
Supercortisol
Ulacort
Ultra Pred
Ultracorten H
Ultracortene H
Ultracortene-H
Ultracortene-hydrogen
Ultracortene-Hydrogen
UNII-9PHQ9Y1OLM
ZINC03833821
δ(1)-dehydrocortisol
δ(1)-dehydrohydrocortisone
δ(1)-hydrocortisone
|
|
6 |
|
Prednisone |
Approved, Vet_approved |
Phase 4,Not Applicable |
|
53-03-2 |
5865
|
Synonyms:
(1S,2R,10S,11S,14R,15S)-14-hydroxy-14-(2-hydroxyacetyl)-2,15-dimethyltetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadeca-3,6-diene-5,17-dione
(8S,9S,10R,13S,14S,17R)-17-hydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-6,7,8,9,12,14,15,16-octahydrocyclopenta[a]phenanthrene-3,11-dione
(8xi,9xi,14xi)-17,21-dihydroxypregna-1,4-diene-3,11,20-trione
.delta. E
.delta.(sup1)-Cortisone
.delta.1-Cortisone
.delta.1-Dehydrocortisone
.delta.-Cortelan
.delta.-Cortisone
.delta.-Cortone
.delta.-E
.delta.sone
1,2-Dehydrocortisone
1,4-Pregnadiene-17.alpha.,21-diol-3,11,20-trione
1,4-Pregnadiene-17a,21-diol-3,11,20-trione
1,4-Pregnadiene-17alpha,21-diol-3,11,20-trione
1,4-Pregnadiene-17-alpha,21-diol-3,11,20-trione
1,4-Pregnadiene-17α,21-diol-3,11,20-trione
17,21-Dihydroxypregna-1,4-diene-3,11,20-trione
17alpha,21-Dihydroxy-1,4-pregnadiene-3,11,20-trione
1-Cortisone
1-Dehydrocortisone
53-03-2
68-59-7
81552_FLUKA
AC-11112
AC1L1LB2
AC1Q29EZ
Acis brand OF prednisone
ACon0_000082
ACon1_000297
Adasone
AI3-52939
Ancortone
apo-Prednisone
Apo-prednisone
Apo-Prednisone
Apotex brand OF prednisone
Aventis brand OF prednisone
Betapar
Bicortone
Bio-0649
BPBio1_000323
BRD-K85883481-001-04-2
BSPBio_000293
C07370
C21H26O5
Cartancyl
CCRIS 2646
CHEBI:8382
CHEMBL635
CID5865
Colisone
Cortan
Cortancyl
Cortidelt
Cotone
CPD001227202
Cutason
Dacorten
Dacortin
DB00635
Decortancyl
Decortin
Decortisyl
Dehydrocortisone
Dekortin
Delcortin
Dellacort
Dellacort A
delta cortelan
Delta Cortelan
Delta E
Delta E.
delta(sup 1)-Cortisone
delta(sup 1)-Dehydrocortisone
delta-1-Cortisone
delta-1-Dehydrocortisone
Delta-cortelan
Delta-Cortelan
Deltacortene
delta-Cortisone
Deltacortisone
Delta-cortisone
delta-Cortone
Deltacortone
Delta-cortone
Delta-dome
Delta-Dome
Deltasone
Deltasone, Liquid Pred, Orasone, Adasone, Deltacortisone,Prednisone
Deltison
Deltisona
Deltisone
Deltra
Diadreson
Di-Adreson
Diba brand OF prednisone
Econosone
EINECS 200-160-3
Encorton
Encortone
Enkortolon
Enkorton
Fawns and mcallan brand OF prednisone
Fernisone
Ferring brand OF prednisone
Fiasone
GALENpharma brand OF prednisone
Halsey drug brand OF prednisone
Hexal brand OF prednisone
HMS1568O15
HMS2090J13
|
Hoechst brand OF prednisone
Hostacortin
HSDB 3168
ICN brand OF prednisone
Incocortyl
In-Sone
Juvason
Kortancyl
Lichtenstein brand OF prednisone
Liquid pred
Liquid Pred
Lisacort
LMST02030180
Lodotra
LS-1325
MEGxm0_000443
Me-Korti
Merck brand OF prednisone
Merz brand OF prednisone
Metacortandracin
Meticorten
Meticorten (Veterinary)
Metrevet (Veterinary)
Mibe brand OF prednisone
MLS001061265
MLS001304073
MLS001335907
MLS001335908
MLS002154191
MLS002207083
MolPort-001-740-041
NCGC00090766-01
NCGC00090766-02
NCGC00090766-03
NCI60_000008
NCI-C04897
Nisona
Nizon
Novoprednisone
NSC 10023
NSC10023
Nurison
Orasone
Origen Prednisone
P1276
P6254_SIGMA
Panafcort
Panasol
Paracort
Parmenison
Pehacort
Pharmacia brand OF prednisone
PRD
Precort
Predeltin
Predni tablinen
Prednicen-M
Prednicorm
Prednicort
Prednicot
Prednidib
Prednilonga
Predniment
Prednison
Prednison acsis
Prednison galen
Prednison hexal
Prednisona
Prednisona [INN-Spanish]
Prednisone
Prednisone [INN:BAN]
Prednisone Intensol
Prednisonum
Prednisonum [INN-Latin]
Prednitone
Prednizon
Prednovister
Presone
Prestwick_405
Prestwick0_000077
Prestwick1_000077
Prestwick2_000077
Prestwick3_000077
Pronison
Pronisone
Rectodelt
Retrocortine
S1622_Selleck
SAM002264641
Schering-plough brand OF prednisone
Seatrace brand OF prednisone
Servisone
SK-Prednisone
SMR000718760
SMR001227202
Solvay brand OF prednisone
Sone
SPBio_002214
Sterapred
Supercortil
Trommsdorff brand OF prednisone
U 6020
Ultracorten
Ultracortene
UNII-VB0R961HZT
Winpred
WLN: L E5 B666 CV OV AHTTT&J A1 E1 FV1Q FQ
Wojtab
Zenadrid
Zenadrid (veterinary)
Zenadrid [veterinary]
ZINC03875357
|
|
7 |
|
Methylprednisolone |
Approved, Vet_approved |
Phase 4 |
|
83-43-2 |
6741
|
Synonyms:
(6a,11b)-11,17,21-Trihydroxy-6-methylpregna-1,4-diene-3,20-dione
(6alpha,11beta)-11,17,21-Trihydroxy-6-methylpregna-1,4-diene-3,20-dione
(6S,8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-17-(2-hydroxyacetyl)-6,10,13-trimethyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-3-one
(6α,11β)-11,17,21-trihydroxy-6-methylpregna-1,4-diene-3,20-dione
.DELTA.1-6.alpha.-Methylhydrocortisone
11beta,17,21-Trihydroxy-6alpha-methylpregna-1,4-diene-3,20-dione
11-beta,17,21-Trihydroxy-6-alpha-methylpregna-1,4-diene-3,20-dione
11beta,17alpha,21-Trihydroxy-6alpha-methyl-1,4-pregnadiene-3,20-dione
11beta,17alpha,21-Trihydroxy-6alpha-methylpregna-1,4-diene-3,20-dione
121673-01-6
1-dehydro-6alpha-Methylhydrocortisone
1-Dehydro-6alpha-methylhydrocortisone
1-dehydro-6a-Methylhydrocortisone
1-dehydro-6α-methylhydrocortisone
4-08-00-03498 (Beilstein Handbook Reference)
46436_FLUKA
46436_RIEDEL
570-35-4
6 Methylprednisolone
6.alpha.-Methylprednisolone
6923-42-8
6alpha-Methyl-11beta,17alpha,21-trihydroxy-1,4-pregnadiene-3,20-dione
6alpha-methyl-11beta,17alpha,21-triol-1,4-pregnadiene-3,20-dione
6alpha-Methyl-11beta,17alpha,21-triol-1,4-pregnadiene-3,20-dione
6alpha-Methylprednisolone
6-alpha-Methylprednisolone
6a-Methyl-11b,17a,21-triol-1,4-pregnadiene-3,20-dione
6-Methylprednisolone
6α-methyl-11β,17α,21-triol-1,4-pregnadiene-3,20-dione
83-43-2
AC1L1N7A
Artisone-wyeth
Artisone-Wyeth
Besonia
Bio-0658
BPBio1_000174
BRD-K35240538-001-03-1
BRN 2340300
BSPBio_000158
CHEBI:6888
CHEMBL650
CID6741
CPD000058330
D00407
D008775
DB00959
delta(1)-6alpha-Methylhydrocortisone
Delta(1)-6alpha-Methylhydrocortisone
delta(1)-6a-Methylhydrocortisone
delta(sup 1)-6-alpha-Methylhydrocortisone
Depo-Medrol (acetate)
Dopomedrol
EINECS 201-476-4
Esametone
Firmacort
HMS1568H20
HMS2090B13
HSDB 3127
Lemod
LMST02030178
LS-118498
M0639_SIGMA
M1665
Medesone
Medixon
Medlone 21
Medrate
Medric acid
|
Medrol
Medrol (TN)
Medrol adt pak
Medrol Adt Pak
Medrol dosepak
Medrol Dosepak
Medrol, Solu-Medrol, Medrone, Methylprednisolone
Medrone
MEPRDL
Mesopren
Metastab
Methyleneprednisolone
Methylprednisolon
methylprednisolone
Methylprednisolone
Methylprednisolone (JP15/USP/INN)
Methylprednisolone [USAN:INN:BAN:JAN]
Methylprednisolone, 6-alpha
Methylprednisolonum
Methylprednisolonum [INN-Latin]
methylprenisolone
Metilbetasone
Metilprednisolona
Metilprednisolona [INN-Spanish]
Metilprednisolone
Metilprednisolone [Dcit]
Metilprednisolone [DCIT]
Metipred
Metrisone
Metrocort
Metysolon
MLS000028541
MLS001148159
MLS002207191
Moderin
MolPort-002-528-554
NCGC00022735-03
NCI60_001657
Nirypan
Noretona
NSC19987
NSC-19987
Predni N Tablinen
Prednol- L
Pregna-1,4-diene-3,20-dione, 11beta,17,21-trihydroxy-6alpha-methyl- (8CI)
Prestwick_622
Prestwick0_000279
Prestwick1_000279
Prestwick2_000279
Prestwick3_000279
Promacortine
Reactenol
S1733_Selleck
SAM002589984
Sieropresol
SMR000058330
Solomet
SPBio_002377
Summicort
Suprametil
U 7532
UNII-X4W7ZR7023
Urbason
Urbasone
Wyacort
ZINC03875560
δ(1)-6a-methylhydrocortisone
δ(1)-6α-methylhydrocortisone
|
|
8 |
|
Methylprednisolone hemisuccinate |
Approved |
Phase 4 |
|
2921-57-5 |
|
Synonyms:
Methylprednisolone hydrogen succinate
|
Methylprednisolone succinate
|
|
9 |
|
Prednisolone phosphate |
Approved, Vet_approved |
Phase 4 |
|
302-25-0 |
|
Synonyms:
Prednisolone 21-(dihydrogen phosphate)
Prednisolone 21-monophosphate
|
Prednisolone 21-phosphate
|
|
10 |
|
Leflunomide |
Approved, Investigational |
Phase 4 |
|
75706-12-6 |
3899
|
Synonyms:
210165-51-8
4-Isoxazolecarboxamide, 5-methyl-N-(4-(trifluoromethyl)phenyl
4-isoxazolecarboxamide,5-methyl-N-(4-(trifluoromethyl)phenyl)
5-Methylisoxazole-4-(4-trifluoromethyl)carboxanilide
5-Methylisoxazole-4-(4-trifluoromethylcarboxanilide)
5-Methylisoxazole-4-carboxylate (4-trifluoromethyl)anilide
5-Methylisoxazole-4-carboxylic acid (4-trifluoromethyl)anilide
5-Methyl-N-(4-(trifluoromethyl)phenyl)-4-isoxazolecarboxamide
5-methyl-N-[4-(trifluoromethyl)phenyl]-1,2-oxazole-4-carboxamide
5-methyl-N-[4-(trifluoromethyl)phenyl]-4-isoxazolecarboxamide
5-methyl-N-[4-(trifluoromethyl)phenyl]isoxazole-4-carboxamide
75706-12-6
a,a,a-trifluoro-5-Methyl-4-isoxazolecarboxy-P-toluidide
A77 1486
AB00052389
AC1L1GYK
AC1Q2EVA
AC-6796
AKOS000265193
alpha,alpha,alpha-trifluoro-5-Methyl-4-isoxazolecarboxy-P-toluidide
alpha,alpha,alpha-Trifluoro-5-methyl-4-isoxazolecarboxy-p-toluidide
alpha,alpha,alpha-Trifluoro-5-methyl-4-isoxazolecarboxy-P-toluidide
AP-501/42475599
Arava
Arava (TN)
Arava, Leflunomide
Aventis behring brand OF leflunomide
Aventis Behring Brand of Leflunomide
Aventis brand OF leflunomide
Aventis Brand of Leflunomide
Aventis pharma brand OF leflunomide
Aventis Pharma Brand of Leflunomide
BIDD:PXR0189
BPBio1_000930
BRD-K78692225-001-03-9
BSPBio_000844
C045463
C07905
CAS-75706-12-6
CHEBI:6402
CHEMBL960
CID3899
D00749
DB01097
DivK1c_000916
EU-0100649
HMS1570K06
HMS1922M06
HMS2090O12
HMS502N18
Hoechst brand OF leflunomide
Hoechst Brand of Leflunomide
HSDB 7289
HWA 486
HWA-486
I06-2131
IDI1_000916
KBio1_000916
KBio2_000802
KBio2_003370
|
KBio2_005938
KBioSS_000802
L 5025
L5025_SIGMA
Leflunomid
Leflunomida
Leflunomida [INN-Spanish]
leflunomide
Leflunomide
Leflunomide (JAN/USAN/INN)
Leflunomide [USAN:INN]
Leflunomidum
Leflunomidum [INN-Latin]
lefunamide
Lefunomide
Lefunomide [Inn-Spanish]
Lefunomide [INN-Spanish]
Lopac0_000649
Lopac-L-5025
LS-86580
MLS000069648
MLS-0003109.0001
MLS001076267
MolPort-002-345-613
N-(4'-Trifluoromethylphenyl)-5-methylisoxazole-4-carboxamide
N-(4-trifluoromethyphenyl)-5-methylisoxazole-4-carboxamide
N-(4-Trifluoromethyphenyl)-5-methylisoxazole-4-carboxamide
NCGC00015610-01
NCGC00015610-02
NCGC00015610-03
NCGC00015610-07
NCGC00015610-12
NCGC00022625-03
NCGC00022625-04
NCGC00022625-05
NCGC00022625-06
NCGC00022625-07
NCGC00022625-08
NINDS_000916
NSC677411
Prestwick_87
Prestwick0_000772
Prestwick1_000772
Prestwick2_000772
Prestwick3_000772
RS-34821
S1247_Selleck
SMR000058209
SPBio_002783
Spectrum_000322
SPECTRUM1503927
Spectrum5_000850
SU 101
SU 101 (pharmaceutical)
SU101
SU-101
TL8005179
UNII-G162GK9U4W
ZINC00004840
α,α,α-trifluoro-5-methyl-4-isoxazolecarboxy-P-toluidide
|
|
11 |
|
Prednisolone hemisuccinate |
Experimental |
Phase 4 |
|
2920-86-7 |
|
Synonyms:
(+)-prednisolone hemisuccinate
Prednisolonbisuccinat
Prednisolone 21-hemisuccinate
Prednisolone 21-succinate
|
Prednisolone bisuccinate
Prednisolone hydrogen succinate
Prednisolone succinate
|
|
12 |
|
Anti-Infective Agents |
|
Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable |
|
|
|
13 |
|
Anti-Bacterial Agents |
|
Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable |
|
|
|
14 |
|
Antibiotics, Antitubercular |
|
Phase 4,Phase 2,Not Applicable |
|
|
|
15 |
|
Liver Extracts |
|
Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable |
|
|
|
16 |
|
Immunoglobulins |
|
Phase 4,Phase 2,Phase 1,Not Applicable |
|
|
|
17 |
|
Immunosuppressive Agents |
|
Phase 4,Phase 2,Phase 1 |
|
|
|
18 |
|
Immunologic Factors |
|
Phase 4,Phase 2,Phase 1 |
|
|
|
19 |
|
Hormone Antagonists |
|
Phase 4,Phase 1 |
|
|
|
20 |
|
Immunoglobulin G |
|
Phase 4,Phase 1,Phase 2,Not Applicable |
|
|
|
21 |
|
Antibodies |
|
Phase 4,Phase 2,Phase 1,Not Applicable |
|
|
|
22 |
|
Antirheumatic Agents |
|
Phase 4,Phase 1,Phase 2 |
|
|
|
23 |
|
Hormones |
|
Phase 4,Phase 1 |
|
|
|
24 |
|
Anti-Inflammatory Agents |
|
Phase 4,Phase 2,Phase 1 |
|
|
|
25 |
|
glucocorticoids |
|
Phase 4,Phase 1 |
|
|
|
26 |
|
Hormones, Hormone Substitutes, and Hormone Antagonists |
|
Phase 4,Phase 1 |
|
|
|
27 |
|
Bile Acids and Salts |
|
Phase 4,Phase 2,Phase 1 |
|
|
|
28 |
|
Gastrointestinal Agents |
|
Phase 4,Phase 2,Phase 3,Phase 1 |
|
|
|
29 |
|
Topoisomerase Inhibitors |
|
Phase 4 |
|
|
|
30 |
|
Cytochrome P-450 CYP1A2 Inhibitors |
|
Phase 4 |
|
|
|
31 |
|
Renal Agents |
|
Phase 4 |
|
|
|
32 |
|
Cytochrome P-450 Enzyme Inhibitors |
|
Phase 4 |
|
|
|
33 |
|
Anti-Infective Agents, Urinary |
|
Phase 4 |
|
|
|
34 |
|
Antitubercular Agents |
|
Phase 4 |
|
|
|
35 |
|
Methylprednisolone acetate |
|
Phase 4 |
|
|
|
36 |
|
Antineoplastic Agents, Hormonal |
|
Phase 4 |
|
|
|
37 |
|
Prednisolone acetate |
|
Phase 4 |
|
|
|
38 |
|
Bezafibrate |
Approved, Investigational |
Phase 3 |
|
41859-67-0 |
39042
|
Synonyms:
2-(4-{2-[(4-chlorobenzoyl)amino]ethyl}phenoxy)-2-methylpropanoic acid
2-(P-(2-(P-chlorobenzamido)Ethyl)phenoxy)-2-methylpropionate
2-(p-(2-(p-Chlorobenzamido)ethyl)phenoxy)-2-methylpropionic acid
2-(P-(2-(P-chlorobenzamido)Ethyl)phenoxy)-2-methylpropionic acid
2-(P-(2-(P-Chlorobenzamido)ethyl)phenoxy)-2-methylpropionic acid
2-[4-(2-[4-Chlorobenzamido]ethyl)- phenoxy]-2-methylpropanoic acid
2-[4-[2-(4-Chlorobenzamido)ethyl]phenoxy]-2-methylpropanoic acid
2-[4-[2-(4-Chlorobenzamido)ethyl]phenoxy]isobutyric Acid
2-[4-[2-[(4-chlorobenzoyl)amino]ethyl]phenoxy]-2-methylpropanoic acid
41859-67-0
a-[4-(4-chlorobenzoylaminoethyl)phenoxy]isobutyric acid
AB00052265
AB1004588
AC1L20XS
AC1Q5E4V
AC-6817
AKOS005107743
Azufibrat
Azupharma brand OF bezafibrate
Azupharma Brand of Bezafibrate
B3346
B7273_SIGMA
Bayer brand OF bezafibrate
Bayer Brand of Bezafibrate
Befibrat
Befizal
Béfizal
Berlin chemie brand OF bezafibrate
Berlin Chemie Brand of Bezafibrate
Berlin-chemie brand OF bezafibrate
Berlin-Chemie Brand of Bezafibrate
Betapharm brand OF bezafibrate
Betapharm Brand of Bezafibrate
Beza lande
Beza Lande
Beza puren
Beza Puren
Bezabeta
Bezacur
Bezafibrat
Bezafibrat PB
bezafibrate
Bezafibrate (JP15/USAN/INN)
Bezafibrate [USAN:BAN:INN:JAN]
Bezafibrate azupharma brand
Bezafibrate Azupharma Brand
Bezafibrate bayer brand
Bezafibrate Bayer Brand
Bezafibrate berlin-chemie brand
Bezafibrate Berlin-Chemie Brand
Bezafibrate betapharm brand
Bezafibrate Betapharm Brand
Bezafibrate cryopharma brand
Bezafibrate Cryopharma Brand
Bezafibrate elfar brand
Bezafibrate Elfar Brand
Bezafibrate hennig brand
Bezafibrate Hennig Brand
Bezafibrate hexal brand
Bezafibrate Hexal Brand
Bezafibrate isis brand
Bezafibrate Isis Brand
Bezafibrate lakeside brand
Bezafibrate Lakeside Brand
Bezafibrate merckle brand
Bezafibrate Merckle Brand
Bezafibrate roche brand
Bezafibrate Roche Brand
Bezafibrate synthelabo brand
Bezafibrate Synthelabo Brand
Bezafibrate tad brand
Bezafibrate TAD Brand
Bezafibrate teva brand
Bezafibrate Teva Brand
Bezafibrato
Bezafibrato [INN-Spanish]
Bezafibrato [Spanish]
Bezafibratum
Bezafibratum [INN-Latin]
Bezafibric acid
Bezafisal
Beza-lande
BezaLande
Beza-Lande
Bezalip
Bezalip Retard
Bezamerck
Beza-puren
BezaPuren
Beza-Puren
Bezatol
Bezatol SR
Bezatol sr (tn)
Bezatol SR (TN)
BF-759
Bio2_000034
Bio2_000514
BM 15.075
BM 15075
BM15.075
BM-15.075
BM-15075
Boehringer mannheim brand OF bezafibrate
Boehringer Mannheim Brand of Bezafibrate
BPBio1_000589
BRD-K46018455-001-06-0
|
BRN 4267656
BSPBio_000535
BSPBio_001314
BSPBio_003119
C19H20ClNO4
CAS-41859-67-0
CCRIS 9085
Cedur
CHEBI:47612
CHEMBL264374
CID39042
Cryopharma brand OF bezafibrate
Cryopharma Brand of Bezafibrate
D001629
D01366
DB01393
DB08380
Difaterol
DivK1c_000092
durabezur
Durabezur
EINECS 255-567-9
Elfar brand OF bezafibrate
Elfar Brand of Bezafibrate
Eulitop
Hennig brand OF bezafibrate
Hennig Brand of Bezafibrate
Hexal brand OF bezafibrate
Hexal Brand of Bezafibrate
HMS1361B16
HMS1569K17
HMS1791B16
HMS1921H16
HMS1989B16
HMS2089F04
HMS2092B12
HMS500E14
I06-1311
IDI1_000092
IDI1_033784
Isis brand OF bezafibrate
Isis Brand of Bezafibrate
KBio1_000092
KBio2_000034
KBio2_001923
KBio2_002602
KBio2_004491
KBio2_005170
KBio2_007059
KBio3_000067
KBio3_000068
KBio3_002619
KBioGR_000034
KBioGR_000669
KBioSS_000034
KBioSS_001923
Lakeside brand OF bezafibrate
Lakeside Brand of Bezafibrate
Lipox
LO 44
LS-124535
Merckle brand OF bezafibrate
Merckle Brand of Bezafibrate
MLS000028533
MLS001148205
MolPort-001-738-424
NCGC00016850-01
NCGC00016850-02
NCGC00016850-11
NCGC00023317-03
NCGC00023317-04
NCGC00023317-05
NCGC00023317-06
NCGC00023317-07
NCGC00023317-08
NINDS_000092
PB, Bezafibrat
Prestwick_724
Prestwick0_000378
Prestwick1_000378
Prestwick2_000378
Prestwick3_000378
Reducterol
Regadrin b
Regadrin B
Roche brand OF bezafibrate
Roche Brand of Bezafibrate
Sklerofibrat
SMR000058298
Solibay
SPBio_000824
SPBio_002456
Spectrum_001443
SPECTRUM1502046
Spectrum2_000922
Spectrum3_001500
Spectrum4_000325
Spectrum5_001079
Spectrum5_001967
ST51014927
synthelabo Brand OF bezafibrate
Synthelabo Brand of Bezafibrate
TAD brand OF bezafibrate
TAD Brand of Bezafibrate
Teva brand OF bezafibrate
Teva Brand of Bezafibrate
|
|
39 |
|
Ursodeoxycholic acid |
Approved, Investigational |
Phase 2, Phase 3,Phase 1 |
|
128-13-2 |
31401
|
Synonyms:
(3a,5b,7b)-3,7-Dihydroxycholan-24-Oate
(3a,5b,7b)-3,7-Dihydroxy-cholan-24-Oate
(3a,5b,7b)-3,7-Dihydroxycholan-24-Oic acid
(3a,5b,7b)-3,7-Dihydroxy-cholan-24-Oic acid
(3alpha,5beta,7beta)-3,7-Dihydroxycholan-24-Oate
(3alpha,5beta,7beta)-3,7-dihydroxycholan-24-oic acid
(3alpha,5beta,7beta)-3,7-Dihydroxycholan-24-Oic acid
(3alpha,5beta,7beta,8xi)-3,7-dihydroxycholan-24-oic acid
(3α,5β,7β)-3,7-dihydroxycholan-24-Oate
(3α,5β,7β)-3,7-dihydroxycholan-24-oic acid
(3α,5β,7β)-3,7-dihydroxycholan-24-Oic acid
(4R)-4-[(3R,5S,7S,8R,9S,10S,13R,14S,17R)-3,7-dihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoic acid
128-13-2
17-beta-(1-Methyl-3-carboxypropyl)etiocholane-3-alpha,7-beta-diol
3 alpha,7 beta Dihydroxy 5 beta cholan 24 Oic acid
3 alpha,7 beta-Dihydroxy-5 beta-cholan-24-oic Acid
3 alpha,7 beta-Dihydroxy-5 beta-cholan-24-Oic acid
3,7-Dihydroxycholan-24-oic acid
3,7-Dihydroxycholan-24-Oic acid
3a,7b-Dihydroxy-5b-cholan-24-Oate
3a,7b-Dihydroxy-5b-cholan-24-Oic acid
3alpha,7beta-Dihydroxy-5beta-cholan-24-Oate
3alpha,7beta-Dihydroxy-5beta-cholan-24-oic acid
3alpha,7beta-Dihydroxy-5beta-cholan-24-Oic acid
3alpha,7beta-Dihydroxy-5beta-cholanic acid
3-alpha,7-beta-Dihydroxy-5-beta-cholanoic acid
3-alpha,7-beta-Dihydroxycholanic acid
3-alpha,7-beta-Dioxycholanic acid
3α,7β-dihydroxy-5β-cholan-24-Oate
3α,7β-dihydroxy-5β-cholan-24-Oic acid
4-10-00-01604 (Beilstein Handbook Reference)
50809-41-1
5beta-Cholan-24-oic acid-3alpha,7beta-diol
5beta-Cholanic Acid-3alpha,7beta-diol
7beta-Hydroxylithocholic acid
7-beta-Hydroxylithocholic acid
80225-86-1
AB00513977
AC-18919
AC1L1LJH
AC-2081
Acid, deoxyursocholic
Acid, ursacholic
Acid, ursodeoxycholic
Acide ursodesoxycholique
Acide ursodesoxycholique [INN-French]
Acido ursodeossicolico
Acido ursodeossicolico [Italian]
Acido ursodeoxicolico
Acido ursodeoxicolico [INN-Spanish]
Acidum ursodeoxycholicum
Acidum ursodeoxycholicum [INN-Latin]
Actigall
Actigall (TN)
Antigall
Antigen brand OF ursodeoxycholic acid
Arsacol
Aventis brand OF ursodeoxycholic acid
Axcan brand OF ursodeoxycholic acid
BB_NC-2372
BPBio1_001052
BRN 3219888
BSPBio_000956
C07880
C24H40O4
CCRIS 5502
CHEBI:9907
CHEMBL1551
CHEMBL73390
chenodeoxycholic acid
Cholan-24-oic acid, 3,7-dihydroxy-, (3-alpha,5-beta,7-beta)- (9CI)
Cholit-ursan
Cholofalk
CID11516715
CID31401
CP Brand OF ursodeoxycholic acid
CPD000058403
CPD-10534
D00734
DB01586
Delursan
Deoxyursocholic acid
Deoxyursocholic Acid
Destolit
Deursil
Dom-ursodiol c
EINECS 204-879-3
Estedi brand OF ursodeoxycholic acid
|
Falk brand OF ursodeoxycholic acid
Farmasa brand OF ursodeoxycholic acid
Galen brand OF ursodeoxycholic acid
Heumann brand OF ursodeoxycholic acid
HMS1570P18
ISO-URSODEOXYCHOLIC ACID
IU5
Litursol
LMST04010033
LS-53033
Lyeton
MLS000028461
MLS001066373
MolPort-001-794-630
MolPort-005-932-884
NCGC00179363-01
NCI60_028904
Niddapharm brand OF ursodeoxycholic acid
Norgine brand OF ursodeoxycholic acid
NSC 657950
NSC 683769
Orphan brand OF ursodeoxycholic acid
Peptarom
PHL-ursodiol c
PMS-ursodiol c
Prestwick0_000958
Prestwick1_000958
Prestwick2_000958
Prestwick3_000958
Provalis brand OF ursodeoxycholic acid
S1643_Selleck
SAM002264653
Sanofi synthelabo brand OF ursodeoxycholic acid
SMP2_000012
SMR000058403
Sodium ursodeoxycholate
Sodium Ursodeoxycholate
Solutrat
SPBio_003105
tramedico Brand OF ursodeoxycholic acid
U0030
U5127_SIGMA
U-9000
UDCA
UDCS
UNII-724L30Y2QR
Urdox
Urosdesoxycholate
Urosdesoxycholic acid
Urosiol
Ursacholic acid
Ursacholic Acid
Ursacol
Urso
UrSO
Urso (TN)
Urso 250
Urso DS
Urso Forte
urso Heumann
Ursobilane
Ursobilin
Ursochol
Ursodamor
Ursodeoxy cholic acid
ursodeoxycholate
Ursodeoxycholate
Ursodeoxycholate, sodium
Ursodeoxycholic acid
URSODEOXYCHOLIC ACID
Ursodeoxycholic acid (JP15/INN)
Ursodeoxycholic acid, UDCA, Ursosan, Ursofalk, Urso Forte, Udiliv, Ursodiol
Ursodeoxycholicacid
Ursodesoxycholic acid
Ursodexycholate
Ursodexycholic acid
Ursodexycholic Acid
ursodiol
Ursodiol
Ursodiol (USP)
Ursodiol [USAN]
Ursofalk
Ursogal
Ursolite
Ursolvan
Ursosan
Vita brand OF ursodeoxycholic acid
Zambon brand OF ursodeoxycholic acid
|
|
40 |
|
Lipid Regulating Agents |
|
Phase 3,Phase 1,Phase 2 |
|
|
|
41 |
|
Antimetabolites |
|
Phase 3,Phase 1,Phase 2,Not Applicable |
|
|
|
42 |
|
Hypolipidemic Agents |
|
Phase 3,Phase 1,Phase 2 |
|
|
|
43 |
|
Cholagogues and Choleretics |
|
Phase 2, Phase 3,Phase 1 |
|
|
|
44 |
|
Dobutamine |
Approved |
Phase 2 |
|
34368-04-2 |
36811
|
Synonyms:
(+-)-4-(2-((3-(p-Hydroxyphenyl)-1-methylpropyl)amino)ethyl)pyrocatechol
(+-)-4-(2-((3-(P-Hydroxyphenyl)-1-methylpropyl)amino)ethyl)pyrocatechol
3,4-dihydroxy-N-[3-(4-hydroxyphenyl)-1-methylpropyl]-beta-phenylethylamine
3,4-Dihydroxy-N-[3-(4-hydroxyphenyl)-1-methylpropyl]-beta-phenylethylamine
3,4-Dihydroxy-N-[3-(4-hydroxyphenyl)-1-methylpropyl]-b-phenylethylamine
3,4-Dihydroxy-N-[3-(4-hydroxyphenyl)-1-methylpropyl]-β-phenylethylamine
34368-04-2
34368-04-2 (Parent)
4-(2-{[3-(4-hydroxyphenyl)-1-methylpropyl]amino}ethyl)benzene-1,2-diol
4-(2-{[4-(4-hydroxyphenyl)butan-2-yl]amino}ethyl)benzene-1,2-diol
4-[2-[4-(4-hydroxyphenyl)butan-2-ylamino]ethyl]benzene-1,2-diol
4-{2-[3-(4-hydroxy-phenyl)-1-methyl-propylamino]-ethyl}-benzene-1,2-diol
52663-81-7 (hydrochloride)
74753-15-4
74753-15-4 (hydrobromide)
AC1L1WFF
AC1Q7AD1
Boehringer ingelheim brand OF dobutamine hydrochloride
BPBio1_000489
BRD-A78322124-003-03-3
BSPBio_000443
C06967
CHEBI:4670
CHEMBL926
CID36811
D03879
DB00841
DL-dobutamine
DL-Dobutamine
Dobucor
Dobuject
Dobutamin
Dobutamin fresenius
Dobutamin hexal
Dobutamin ratiopharm
Dobutamin solvay
Dobutamina
Dobutamina [INN-Spanish]
Dobutamina inibsa
Dobutamina rovi
dobutamine
Dobutamine
Dobutamine (+)-isomer
Dobutamine (USP/INN)
Dobutamine [Usan:Ban:Inn]
Dobutamine [USAN:BAN:INN]
Dobutamine [Usan]
Dobutamine [USAN]
Dobutamine Hcl
Dobutamine Hcl in Dextrose 5%
Dobutamine hydrobromide
Dobutamine hydrochloride
Dobutamine Hydrochloride
Dobutamine lactobionate
|
Dobutamine phosphate (1:1) salt, (-)-isomer
Dobutamine tartrate
Dobutamine tartrate (1:1), (R-(r*,r*))-isomer
Dobutamine tartrate (1:1), (S-(r*,r*))-isomer
Dobutamine Tartrate (1:1), (S-(R*,R*))-Isomer
dobutamine(usp)
Dobutamine, (-)-isomer
Dobutamine, phosphate (1:1) salt (+)-isomer
Dobutamin-ratiopharm
Dobutaminum
Dobutaminum [INN-Latin]
Dobutrex
EINECS 277-982-4
Eli lilly brand OF dobutamine hydrochloride
Fresenius brand OF dobutamine hydrochloride
Hexal brand OF dobutamine hydrochloride
HMS2089K05
Hydrobromide, dobutamine
Hydrochloride, dobutamine
Inibsa brand OF dobutamine hydrochloride
Inotrex
Irisfarma brand OF dobutamine hydrochloride
Juste brand OF dobutamine hydrochloride
Kendrick brand OF dobutamine hydrochloride
L001157
Lactobionate, dobutamine
Lilly 81929
Lilly brand OF dobutamine hydrochloride
Lopac0_000365
LS-174467
LY 81929
NCGC00015321-05
NCGC00024629-02
NCGC00024629-03
Oxiken
Pisa brand OF dobutamine hydrochloride
Posiject
Prestwick0_000352
Prestwick1_000352
Prestwick2_000352
Prestwick3_000352
rac-dobutamine
rac-Dobutamine
racemic-Dobutamine
Racemic-dobutamine
Racemic-Dobutamine
Ratiopharm brand OF dobutamine hydrochloride
Rovi brand OF dobutamine hydrochloride
Solvay brand OF dobutamine hydrochloride
SPBio_002364
Tartrate, dobutamine
UNII-0WR771DJXV
UNII-3S12J47372
|
|
45 |
|
Norepinephrine |
Approved |
Phase 2 |
|
51-41-2 |
439260
|
Synonyms:
(-)-(R)-Norepinephrine
(-)-alpha-(Aminomethyl)protocatechuyl alcohol
(-)-Arterenol
(-)-Arterenol free base
(-)-Noradrenaline
(-)-NORADRENALINE
(-)-Norepinephrine
(R)-(-)-Norepinephrine
(R)-4-(2-amino-1-Hydroxyethyl)-1,2-benzenediol
(R)-4-(2-Amino-1-hydroxyethyl)-1,2-benzenediol
(R)-Noradrenaline
(R)-Norepinephrine
1,2-Benzenediol, 4-(2-amino-1-hydroxyethyl)-, (R)- (9CI)
4-(2-amino-1-Hydroxyethyl)-1,2-benzenediol
4-[(1R)-2-amino-1-Hydroxyethyl]-1,2-benzenediol
4-[(1R)-2-Amino-1-hydroxyethyl]-1,2-benzenediol
4-[(1R)-2-amino-1-hydroxyethyl]benzene-1,2-diol
4899-05-2
51-40-1 (l-tartrate (1:1))
51-41-2
66197-73-7
A7257_SIGMA
Abbott brand OF levophed bitartrate
AC1L96ZT
Adrenor
Aktamin
ALBB-006229
Arterenol
Aventis brand OF norepinephrine hydrochloride
Bitartrate, levophed
Bitartrate, noradrenaline
Bitartrate, norepinephrine
bmse000404
BRN 4231961
BSPBio_002079
C00547
CHEBI:18357
CHEMBL1437
CID439260
D-(-)-Noradrenaline
D00076
D53D5E3A-2360-4CA9-8031-6C2CD4062FD5
DB00368
DivK1c_000230
EINECS 200-096-6
HMS1920B08
HMS2089E18
HMS2091J08
HMS500L12
Hydrochloride, norepinephrine
IDI1_000230
KBio1_000230
KBio2_001489
KBio2_004057
KBio2_006625
KBio3_001579
KBioGR_000635
KBioSS_001489
l-1-(3,4-Dihydroxyphenyl)-2-aminoethanol
l-2-Amino-1-(3,4-dihydroxyphenyl)ethanol
L-2-amino-1-(3,4-Dihydroxyphenyl)ethanol
L-3,4-dihydroxyphenylethanolamine
L-3,4-Dihydroxyphenylethanolamine
L-alpha-(aminomethyl)-3,4-dihydroxybenzyl alcohol
L-alpha-(Aminomethyl)-3,4-dihydroxybenzyl alcohol
L-arterenol
L-Arterenol
Levarterenol
Levarterenolo
Levarterenolo [DCIT]
Levoarterenol
Levonor
Levonoradrenaline
Levonorepinephrine
Levophed
Levophed bitartrate
L-noradrenaline
|
L-Noradrenaline
L-Norepinephrine
L-NOREPINEPHRINE
LS-42676
LT03330026
LT4
NCGC00159406-02
NCGC00159406-03
NCGC00159406-04
NCGC00159406-05
NCGC00159406-06
NCGC00159406-07
NCGC00159406-09
nchembio.284-comp2
nchembio.64-comp2
nchembio705-1
NINDS_000230
Nor adrenalin
Nor adrenalin (TN)
Noradrenalin
Noradrenalina
Noradrenalina [Italian]
noradrenaline
Noradrenaline
Nor-adrenaline
Noradrenaline (JP15)
Noradrenaline bitartrate
Noradrénaline tartrate renaudin
Noradrenalinum
Norartrinal
Noreinefrina
Noreinefrina [INN-Spanish]
norepinefrina
Norepinefrina
Norepinephrin D-tartrate (1:1)
norepinephrine
Norepinephrine
Norepinephrine (INN)
Norepinephrine [INN:JAN]
Norepinephrine bitartrate
Norepinephrine D-tartrate (1:1)
Norepinephrine hydrochloride
Norepinephrine hydrochloride, (+)-isomer
Norepinephrine hydrochloride, (+,-)-isomer
Norepinephrine l-Tartrate (1:1)
Norepinephrine L-tartrate (1:1)
Norepinephrine L-tartrate (1:1), (+,-)-isomer
Norepinephrine L-tartrate (1:1), monohydrate
Norepinephrine L-tartrate (1:1), monohydrate, (+)-isomer
Norepinephrine L-tartrate (1:2)
Norepinephrine L-tartrate, (+)-isomer
Norepinephrine Noradrenalin
Norepinephrine, (+)-isomer
Norepinephrine, (+,-)-isomer
norepinephrinum
Norepinephrinum
Norepinephrinum [INN-Latin]
Norepirenamine
Nor-epirenan
PDSP1_001111
PDSP2_001095
Renaudin brand OF norepinephrine bitartrate
Renaudin, noradrénaline tartrate
SGCUT00123
SPBio_001048
Spectrum_001009
SPECTRUM1500436
Spectrum2_001064
Spectrum3_000520
Spectrum4_000078
Spectrum5_001068
STK503776
Sympathin e
Sympathin E
Tartrate renaudin, noradrénaline
to_000024
UNII-X4W3ENH1CV
|
|
46 |
|
chenodeoxycholic acid |
Approved |
Phase 2 |
|
474-25-9 |
10133
|
Synonyms:
(+)-Chenodeoxycholate
(+)-Chenodeoxycholic acid
(3a,5b,7a)-3,7-Dihydroxy-cholan-24-Oate
(3a,5b,7a)-3,7-Dihydroxy-cholan-24-Oic acid
3a,7a-Dihydroxy-5b,14a,17b-cholanate
3a,7a-Dihydroxy-5b,14a,17b-cholanic acid
3a,7a-Dihydroxy-5b-cholan-24-Oate
3a,7a-Dihydroxy-5b-cholan-24-Oic acid
3a,7a-Dihydroxy-5b-cholanate
3a,7a-Dihydroxy-5b-cholanic acid
3alpha,7alpha-Dihydroxy-5beta-cholanate
3alpha,7alpha-Dihydroxy-5beta-cholanic acid
3α,7α-dihydroxy-5β-cholanate
3α,7α-dihydroxy-5β-cholanic acid
7a-Hydroxy-desoxycholsaeure
7a-Hydroxylithocholate
7a-Hydroxylithocholic acid
7alpha-Hydroxylithocholate
7alpha-Hydroxylithocholic acid
7α-hydroxylithocholate
7α-hydroxylithocholic acid
Acid, chenic
Acid, chenique
Acid, chenodeoxycholic
Acid, gallodesoxycholic
Anthropodeoxycholate
Anthropodeoxycholic acid
Anthropodesoxycholate
|
Anthropodesoxycholic acid
Antigen brand OF chenodeoxycholic acid
CDCA
Chenate
Chenic acid
Chenique acid
Chenix
Chenocholic acid
Chenodeoxycholate
Chenodeoxycholate, sodium
Chenodeoxycholic acid
Chenodesoxycholic acid
Chenodesoxycholsaeure
Chenodiol
Chenofalk
Chenophalk
Estedi brand OF chenodeoxycholic acid
Falk brand OF chenodeoxycholic acid
Gallodesoxycholate
Gallodesoxycholic acid
Henohol
Quenobilan
Quenocol
Sodium chenodeoxycholate
Solvay brand OF chenodeoxycholic acid
tramedico Brand OF chenodeoxycholic acid
Zambon brand OF chenodeoxycholic acid
|
|
47 |
|
Cladribine |
Approved, Investigational |
Phase 2 |
|
4291-63-8 |
20279
|
Synonyms:
(2R,3S,5R)-5-(6-amino-2-chloropurin-9-yl)-2-(hydroxymethyl)oxolan-3-ol
(2R,3S,5R)-5-(6-amino-2-Chloropurin-9-yl)-2-(hydroxymethyl)oxolan-3-ol
2 Chlorodeoxyadenosine
24757-90-2
2CdA
2-CdA
2-chloro-2'-Deoxyadenosine
2-Chloro-2'-deoxyadenosine
2-chloro-2'-Deoxy-b-adenosine
2-chloro-2'-Deoxy-beta-adenosine
2-Chloro-2'-deoxy-beta-adenosine
2-chloro-2'-Deoxy-β-adenosine
2-chloro-6-amino-9-(2-Deoxy-b-D-erythro-pentofuranosyl)purine
2-chloro-6-amino-9-(2-deoxy-beta-D-erythro-pentofuranosyl)purine
2-chloro-6-amino-9-(2-Deoxy-beta-D-erythro-pentofuranosyl)purine
2-Chloro-6-amino-9-(2-deoxy-beta-D-erythropentofuranosyl)purine
2-chloro-6-amino-9-(2-Deoxy-β-D-erythro-pentofuranosyl)purine
2-chloro-deoxyadenosine
2-chloro-Deoxyadenosine
2-Chlorodeoxyadenosine
2ClAdo
2'-Deoxy-2-chloroadenosine
4291-63-8
AC1L2FXP
AC-7591
Adenosine, 2-chloro-2'-deoxy
BRN 0624220
C10H12ClN5O3.C3H8
CHEBI:567361
CHEMBL1619
Chlorodeoxyadenosine
CID20279
CL9
Cladarabine
Cladaribine
cladribina
Cladribina
cladribine
Cladribine
|
Cladribine (JAN/USAN/INN)
Cladribine [USAN:INN:BAN]
cladribinum
Cladribinum
CldAdo
CPD000058553
D01370
D017338
DB00242
FT-0080707
HMS2052K13
HSDB 7564
Leustat
Leustatin
Leustatin (TN)
Leustatin, 2-chlorodeoxyadenosine, Cladribine
Litak
LS-15109
MLS000028377
MLS000028484
MLS000759397
MLS001077345
MolPort-002-054-532
MolPort-005-935-074
Movectro
Mylinax
NCGC00022567-05
NCGC00164384-01
NSC 105014
NSC 105014-F
NSC-105014
RWJ 26251
RWJ-26251
RWJ-26251-000
S1199_Selleck
SAM001246526
SMR000058553
UNII-47M74X9YT5
ZINC03798064
|
|
48 |
|
rituximab |
Approved |
Phase 1, Phase 2 |
|
174722-31-7 |
10201696
|
Synonyms:
AntiCD20
IDEC-102
IDEC-C2B8
Ig gamma-1 chain C region
|
Mabthera
MabThera
Rituxan
rituximab
|
|
49 |
|
Sulfasalazine |
Approved |
Phase 2 |
|
599-79-1 |
5353980
5359476
|
Synonyms:
13gs
2-HYDROXY-(5-([4-(2-PYRIDINYLAMINO)SULFONYL]PHENYL)AZO)BENZOIC ACID
2-Hydroxy-5-((4-((2-pyridinylamino)sulfonyl)phenyl)azo)benzoate
2-Hydroxy-5-((4-((2-pyridinylamino)sulfonyl)phenyl)azo)benzoic acid
2-Hydroxy-5-((4-((2-pyridinylamino)sulphonyl)phenyl)azo)benzoate
2-Hydroxy-5-((4-((2-pyridinylamino)sulphonyl)phenyl)azo)benzoic acid
2-hydroxy-5-(4-[(pyridin-2-ylamino)sulfonyl]phenyl}diazenyl)benzoic acid
2-hydroxy-5-[(E)-{4-[(pyridin-2-ylamino)sulfonyl]phenyl}diazenyl]benzoic acid
2-Hydroxy-5-[4-(pyridin-2-ylsulfamoyl)-phenylazo]-benzoate
2-Hydroxy-5-[4-(pyridin-2-ylsulfamoyl)-phenylazo]-benzoic acid
2-Hydroxy-5-[4-(pyridin-2-ylsulphamoyl)-phenylazo]-benzoate
2-Hydroxy-5-[4-(pyridin-2-ylsulphamoyl)-phenylazo]-benzoic acid
2-hydroxy-5-{[4-(pyridin-2-ylsulfamoyl)phenyl]diazenyl}benzoic acid
4-(Pyridyl-2-amidosulfonyl)-3'-carboxy-4'-hydroxyazobenzene
4-(Pyridyl-2-amidosulphonyl)-3'-carboxy-4'-hydroxyazobenzene
5-((P-(2-Pyridylsulfamoyl)phenyl)azo)salicylate
5-((p-(2-Pyridylsulfamoyl)phenyl)azo)salicylic acid
5-((P-(2-Pyridylsulfamoyl)phenyl)azo)salicylic acid
5-((P-(2-Pyridylsulphamoyl)phenyl)azo)salicylate
5-((P-(2-Pyridylsulphamoyl)phenyl)azo)salicylic acid
5-(4-(2-Pyridylsulfamoyl)phenylazo)-2-hydroxybenzoate
5-(4-(2-Pyridylsulfamoyl)phenylazo)-2-hydroxybenzoic acid
5-(4-(2-Pyridylsulphamoyl)phenylazo)-2-hydroxybenzoate
5-(4-(2-Pyridylsulphamoyl)phenylazo)-2-hydroxybenzoic acid
5-(p-(2-Pyridinylsulfamoyl)Phenylazo)Salicylic Acid
5-(P-(2-Pyridylsulfamyl)phenylazo)salicylate
5-(p-(2-Pyridylsulfamyl)phenylazo)salicylic acid
5-(P-(2-Pyridylsulfamyl)phenylazo)salicylic acid
5-(P-(2-Pyridylsulphamyl)phenylazo)salicylate
5-(P-(2-Pyridylsulphamyl)phenylazo)salicylic acid
5-(para-(2-pyridylsulfamoyl)phenylazo)salicylic acid
5-[4-(2-Pyridylsulfamoyl)-phenylazo]-salicylic acid
5-[4-(2-Pyridylsulfamoyl)phenylazo]salicylic Acid
5-[p-(2-Pyridylsulfamoyl)phenylazo]salicylic acid
5-[p-(2-Pyridylsulfamyl)phenylazo]salicylic acid
5-22-08-00433 (Beilstein Handbook Reference)
599-79-1
AC1NS4RK
AC1NSE0P
AC1NTMDP
AC1Q72VB
AC-20497
Accucol
AKOS002311709
Alphapharm Brand of Sulfasalazine
Alti-Sulfasalazine
Ashbourne Brand of Sulfasalazine
Asulfidine
Azlufidine EN-Tabs
Azopyrin
Azopyrine
Azosulfidin
Azulfadine
Azulfidine
Azulfidine (TN)
Azulfidine EN
Azulfidine EN-tabs
Azulfidine EN-Tabs
Benzosulfa
BIDD:GT0161
BPBio1_000527
BRD-K10670311-001-06-4
BRN 0356241
BSPBio_000479
BSPBio_002888
C07316
C18H14N4O5S
CAS-599-79-1
CCRIS 4713
CHEBI:45504
CHEBI:489907
CHEBI:9334
CHEMBL242373
CHEMBL421
CID5353980
CID5359476
CID5384001
cMAP_000018
Colo Pleon
Colo-Pleon
CPD000059146
D00448
D012460
DB00795
DB08518
DivK1c_000860
EINECS 209-974-3
EN, Azulfidine
FNA Brand of Sulfasalazine
Henning Berlin Brand of Sulfasalazine
Heyl Brand of Sulfasalazine
HMS1569H21
HMS1921C05
HMS2051J21
HMS2090P13
HMS2092K07
HMS502K22
HSDB 3395
I06-0676
IDI1_000860
KBio1_000860
KBio2_001478
KBio2_002314
KBio2_004046
KBio2_004882
KBio2_006614
|
KBio2_007450
KBio3_002108
KBio3_002794
KBioGR_000753
KBioGR_002314
KBioSS_001478
KBioSS_002316
LS-46
medac Brand of Sulfasalazine
MLS000759399
MLS001424109
MolPort-001-792-507
MolPort-003-986-992
NCGC00016518-01
NCGC00090903-01
NCGC00090903-02
NCGC00090903-03
NCGC00090903-04
NCGC00090903-05
nchembio.212-comp9
NINDS_000860
NSC 203730
NSC 667219
NSC203730
NSC667219
Pfizer Brand of Sulfasalazine
Pleon
PMS-Sulfasalazine
Pms-Sulfasalazine E.C.
Prestwick_848
Prestwick0_000520
Prestwick1_000520
Prestwick2_000520
Prestwick3_000520
Pyralin EN
ratio Sulfasalazine
Ratiopharm Brand of Sulfasalazine
ratio-Sulfasalazine
Reupirin
Rorasul
S.A.S. 500
S.A.S. Enteric-500
S.A.S.-500
S0580
Salazopiridazin
Salazopyridin
Salazopyrin
Salazopyrin en-tabs
Salazopyrin EN-Tabs
Salazosulfapiridina
Salazosulfapiridina [INN-Spanish]
Salazosulfapyridin
Salazosulfapyridine
Salazosulfapyridine (JP15)
Salazosulfapyridinum
Salazo-sulfapyridinum
Salazosulfapyridinum [INN-Latin]
Salazosulphapiridina
Salazosulphapyridine
Salazosulphapyridinum
Salicylazosulfapyridine
Salicylazosulphapyridine
Salisulf
SAM001246530
Sanofi Synthelabo Brand of Sulfasalazine
Sas-500
SASP
SBB058178
SI-88
SMP2_000059
SMR000059146
SPBio_001032
SPBio_002400
Spectrum_000998
SPECTRUM1500552
Spectrum2_001216
Spectrum3_001364
Spectrum4_000347
Spectrum5_001443
SSZ
ST50767935
Sulcolon
Sulfasalazin
Sulfasalazin Heyl
Sulfasalazin medac
Sulfasalazina
Sulfasalazina [INN-Spanish]
sulfasalazine
Sulfasalazine (USP/INN)
Sulfasalazine [USAN:INN]
Sulfasalazine FNA
Sulfasalazine Pfizer Brand
Sulfasalazin-Heyl
Sulfasalazinum
Sulfasalazinum [INN-Latin]
Sulfazalazine
Sulphasalazina
Sulphasalazine
Sulphasalazinum
TL8003811
Ucine
Ulcol
UNII-3XC8GUZ6CB
WLN: T6NJ BSWMR DNUNR DQ CVQ
w-t Sasp oral
W-T Sasp Oral
|
|
50 |
|
Aldesleukin |
Approved |
Phase 2 |
|
85898-30-2, 110942-02-4 |
|
Synonyms:
125-L-serine-2-133-interleukin 2 (human reduced)
Interleukin-2 aldesleukin
|
Interleukin-2(2-133),125-ser
Recombinant interleukin-2 human
|
|
Interventional clinical trials:
(show top 50)
(show all 99)
# |
Name |
Status |
NCT ID |
Phase |
Drugs |
1 |
Effect and Safety of Oral Vancomycin in Primary Sclerosing Cholangitis Patients |
Unknown status |
NCT02605213
|
Phase 4 |
Vancomycin;Placebo |
2 |
Antibiotics to Decrease Post ERCP Cholangitis |
Recruiting |
NCT03087656
|
Phase 4 |
Ceftriaxone;Levofloxacin |
3 |
Leflunomide for Maintenance of Remission in IgG4 Related Disease |
Recruiting |
NCT02703194
|
Phase 4 |
Prednisone;Leflunomide |
4 |
A Pilot Study to Characterize Bile Acid Metabolism and Dysbiosis in Primary Sclerosing Cholangitis |
Active, not recruiting |
NCT02464020
|
Phase 4 |
Vancomycin |
5 |
Short-term Stenting Versus Balloon Dilatation for Dominant Strictures in Primary Sclerosing Cholangitis |
Unknown status |
NCT01398917
|
Phase 3 |
|
6 |
Probiotics in Patients With Primary Sclerosing Cholangitis |
Unknown status |
NCT00161148
|
Phase 3 |
Probiotics |
7 |
The Effect of Bezafibrate on Cholestatic Itch |
Unknown status |
NCT02701166
|
Phase 3 |
Bezafibrate;Placebo |
8 |
Primary Sclerosing Cholangitis With Oral Vancomycin by the Study of Its Antimicrobial and Immunomodulating Effects |
Completed |
NCT01802073
|
Phase 3 |
Oral Vancomycin |
9 |
Trial of High-dose Urso in Primary Sclerosing Cholangitis |
Completed |
NCT00059202
|
Phase 2, Phase 3 |
Ursodeoxycholic Acid |
10 |
Vancomycin for Primary Sclerosing Cholangitis |
Recruiting |
NCT03710122
|
Phase 2, Phase 3 |
Vancomycin |
11 |
Efficacy and Safety of Vedolizumab Intravenous (IV) in the Treatment of Primary Sclerosing Cholangitis in Subjects With Underlying Inflammatory Bowel Disease |
Withdrawn |
NCT03035058
|
Phase 3 |
Vedolizumab;Placebo |
12 |
Molecular Adsorbent Recirculating System (MARS®) in Hypoxic Hepatitis |
Unknown status |
NCT01690845
|
Phase 2 |
|
13 |
PERSEUS: Preliminary Efficacy and Safety of Cenicriviroc in Adult Participants With Primary Sclerosing Cholangitis |
Completed |
NCT02653625
|
Phase 2 |
Cenicriviroc 150 mg |
14 |
Fecal Microbiota Transplantation for the Treatment of Primary Sclerosing Cholangitis. |
Completed |
NCT02424175
|
Phase 1, Phase 2 |
|
15 |
Phase 2 Study of NGM282 in Patients With Primary Sclerosing Cholangitis |
Completed |
NCT02704364
|
Phase 2 |
|
16 |
Obeticholic Acid (OCA) in Primary Sclerosing Cholangitis (PSC) |
Completed |
NCT02177136
|
Phase 2 |
OCA;Placebo |
17 |
Norursodeoxycholic Acid in the Treatment of Primary Sclerosing Cholangitis |
Completed |
NCT01755507
|
Phase 2 |
norUDCA;Placebo |
18 |
Open Label Study to Evaluate Safety and Efficacy of LUM001 in Patients With Primary Sclerosing Cholangitis |
Completed |
NCT02061540
|
Phase 2 |
LUM001 |
19 |
Simtuzumab (GS-6624) in the Prevention of Progression of Liver Fibrosis in Subjects With Primary Sclerosing Cholangitis (PSC) |
Completed |
NCT01672853
|
Phase 2 |
|
20 |
Phase II Pilot Study of Cladribine (2-Chlorodeoxyadenosine; 2-CdA) for Early Stage Primary Sclerosing Cholangitis |
Completed |
NCT00004762
|
Phase 2 |
cladribine |
21 |
Rituximab in IgG4-RD: A Phase 1-2 Trial |
Completed |
NCT01584388
|
Phase 1, Phase 2 |
Rituximab |
22 |
Mitomycin C Therapy for Patients With Primary Sclerosing Cholangitis |
Recruiting |
NCT01688024
|
Phase 2 |
Mitomycin C;Normal saline |
23 |
A Trial of BTT1023 in Patients With Primary Sclerosing Cholangitis |
Recruiting |
NCT02239211
|
Phase 2 |
BTT1023 |
24 |
A Research Study to Evaluate Safety and Efficacy of DUR-928 in Subjects With Primary Sclerosing Cholangitis (PSC) |
Recruiting |
NCT03394781
|
Phase 2 |
DUR-928 |
25 |
Sulfasalazine for the Treatment of Primary Sclerosing Cholangitis |
Recruiting |
NCT03561584
|
Phase 2 |
Sulfasalazine;Placebo |
26 |
A POC and Dose-Ranging Study of HTD1801 in PSC Patients |
Recruiting |
NCT03333928
|
Phase 2 |
HTD1801;Placebo |
27 |
An Efficacy Trial of Low Dose All-trans Retinoic Acid in Patients With Primary Sclerosing Cholangitis |
Recruiting |
NCT03359174
|
Phase 2 |
All-trans retinoic acid |
28 |
Induction of Regulatory t Cells by Low Dose il2 in Autoimmune and Inflammatory Diseases |
Recruiting |
NCT01988506
|
Phase 2 |
Interleukin 2 |
29 |
Umbilical Cord Mesenchymal Stem Cells in Primary Sclerosing Cholangitis |
Active, not recruiting |
NCT03516006
|
Phase 1, Phase 2 |
UCMSC;UDCA |
30 |
A Study Evaluating the Safety and Efficacy of Curcumin in Patients With Primary Sclerosing Cholangitis |
Active, not recruiting |
NCT02978339
|
Phase 1, Phase 2 |
Curcumin |
31 |
Safety, Tolerability, and Efficacy of GS-9674 in Adults With Primary Sclerosing Cholangitis Without Cirrhosis |
Active, not recruiting |
NCT02943460
|
Phase 2 |
GS-9674;Placebo to match GS-9674 |
32 |
A Study of Oral Hymecromone to Treat Adults With Primary Sclerosing Cholangitis |
Not yet recruiting |
NCT02780752
|
Phase 1, Phase 2 |
hymecromone |
33 |
Vidofludimus Calcium for Primary Sclerosing Cholangitis |
Not yet recruiting |
NCT03722576
|
Phase 2 |
Vidofludimus calcium |
34 |
A Study of HTD1801 in Adolescents With Primary Sclerosing Cholangitis (PSC) |
Not yet recruiting |
NCT03678480
|
Phase 2 |
HTD1801;Ursodeoxycholic Acid |
35 |
A Single-arm,Phase IIa,Safety and Efficacy Trial of Selected MSCs in the Treatment of Patients With PSC & AiH |
Not yet recruiting |
NCT02997878
|
Phase 1, Phase 2 |
|
36 |
Thalidomide for the Treatment of Primary Sclerosing Cholangitis (PSC) |
Terminated |
NCT00953615
|
Phase 2 |
Thalidomide |
37 |
Pilot Study of Fenofibrate for PSC |
Terminated |
NCT01142323
|
Phase 1, Phase 2 |
fenofibrate |
38 |
The Value of CT Cholangiography in Primary Sclerosing Cholangitis |
Withdrawn |
NCT00588458
|
Phase 2 |
|
39 |
Gastrointestinal Microbiota in Primary Sclerosing Cholangitis and Biliary Atresia With Vancomycin |
Completed |
NCT01322386
|
Phase 1 |
Vancomycin |
40 |
Erlotinib for Chemoprevention in Trisomy 7 Positive Primary Sclerosing Cholangitis (PSC) |
Completed |
NCT00955149
|
Phase 1 |
Erlotinib (Tarceva) |
41 |
Safety and Efficacy Study of Ursodeoxycholic Acid Therapy in Pediatric Primary Sclerosing Cholangitis |
Completed |
NCT01088607
|
Phase 1 |
ursodeoxycholic acid (UDCA) |
42 |
A Pilot Study of Vancomycin or Metronidazole in Patients With Primary Sclerosing Cholangitis |
Completed |
NCT01085760
|
Phase 1 |
Vancomycin;Vancomycin;Metronidazole;Metronidazole;Vancomycin |
43 |
Minocycline in Primary Sclerosing Cholangitis (PSC) |
Completed |
NCT00630942
|
Phase 1 |
Minocycline |
44 |
A Pilot Study of Xifaxan to Treat Patients With PSC |
Completed |
NCT01695174
|
Phase 1 |
Xifaxan |
45 |
Pilot Study of Budesonide for Patients With Primary Sclerosing Cholangitis |
Completed |
NCT00004842
|
Phase 1 |
budesonide |
46 |
Evaluation of DHA for the Treatment of PSC |
Completed |
NCT00325013
|
Phase 1 |
Docosahexaenoic Acid (DHA) |
47 |
Combination Therapy With Ursodeoxycholic Acid (UDCA) and All-Trans Retinoic Acid (ATRA) for Treatment of Primary Sclerosing Cholangitis |
Completed |
NCT01456468
|
Phase 1 |
Oral all-trans retinoic acid (ATRA) |
48 |
A Study of HTD1801 in Healthy Subjects |
Completed |
NCT03099603
|
Phase 1 |
HTD1801 |
49 |
Biliary Excretion of Conjugated Bile Acids in Humans Measured by 11C-cholylsarcosine PET/CT |
Completed |
NCT01879735
|
Phase 1 |
11C-CSar;ICG |
50 |
Treating Primary Sclerosing Cholangitis and Biliary Atresia With Vancomycin |
Recruiting |
NCT02137668
|
Phase 1 |
Oral Vancomycin |
|